Full text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Stress is a key risk factor in the onset of neuropsychiatric disorders. The study of the mechanisms underlying stress response is important to understand the etiopathogenetic mechanisms and identify new putative therapeutic targets. In this context, microRNAs (miRNAs) have emerged as key regulators of the complex patterns of gene/protein expression changes in the brain, where they have a crucial role in the regulation of neuroplasticity, neurogenesis, and neuronal differentiation. Among them, miR-135a-5p has been associated with stress response, synaptic plasticity, and the antidepressant effect in different brain areas. Here, we used acute unavoidable foot-shock stress (FS) and chronic mild stress (CMS) on male rats to study whether miR-135a-5p was involved in stress-induced changes in the prefrontal cortex (PFC). Both acute and chronic stress decreased miR-135a-5p levels in the PFC, although after CMS the reduction was induced only in animals vulnerable to CMS, according to a sucrose preference test. MiR-135a-5p downregulation in the primary neurons reduced dendritic spine density, while its overexpression exerted the opposite effect. Two bioinformatically predicted target genes, Kif5c and Cplx1/2, were increased in FS rats 24 h after stress. Altogether, we found that miR-135a-5p might play a role in stress response in PFC involving synaptic mechanisms.

Details

Title
Involvement of miR-135a-5p Downregulation in Acute and Chronic Stress Response in the Prefrontal Cortex of Rats
Author
Mingardi, Jessica 1   VIAFID ORCID Logo  ; Paoli, Caterina 2   VIAFID ORCID Logo  ; Luca La Via 3   VIAFID ORCID Logo  ; Carini, Giulia 3   VIAFID ORCID Logo  ; Misztak, Paulina 4 ; Cifani, Carlo 5   VIAFID ORCID Logo  ; Popoli, Maurizio 6   VIAFID ORCID Logo  ; Barbon, Alessandro 3   VIAFID ORCID Logo  ; Musazzi, Laura 4   VIAFID ORCID Logo 

 Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy; Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy 
 Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy; Pharmacology Unit, School of Pharmacy, University of Camerino, 62032 Camerino, Italy 
 Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy 
 Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy 
 Pharmacology Unit, School of Pharmacy, University of Camerino, 62032 Camerino, Italy 
 Department of Pharmaceutical Sciences, University of Milan, 20133 Milan, Italy 
First page
1552
Publication year
2023
Publication date
2023
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2767226948
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.